PEDIATRICS Vol. 110 No. 4 October 2002, pp. 841-845
AMERICAN ACADEMY OF PEDIATRICS |
Smallpox Vaccine
After an extensive worldwide eradication program, the last nonlaboratory case of smallpox occurred in 1977 in Somalia. In 1972, routine smallpox immunization was discontinued in the United States, and since 1983, vaccine production has been halted. Stockpiled vaccine has been used only for laboratory researchers working on orthopoxviruses. In recent years, there has been concern that smallpox virus stocks may be in the hands of bioterrorists, and this concern has been heightened by the terrorist attack on the World Trade Center and the Pentagon on September 11, 2001. Because most of the population is considered to be nonimmune, there is debate as to whether smallpox immunization should be resumed. This statement reviews the current status of smallpox vaccine, the adverse effects that were associated with smallpox vaccine in the past, and the major proposals for vaccine use. The statement provides the rationale for a policy based on the so-called ring vaccination strategy recommended by the Centers for Disease Control and Prevention, in which cases of smallpox are rapidly identified, infected individuals are isolated, and contacts of the infected individuals as well as their contacts are immunized immediately.
Abbreviations: HIV, human immunodeficiency virus CDC, Centers for Disease Control and Prevention VIG, vaccinia immune globulin AAP, American Academy of Pediatrics
Statement of retirement:
- AAP Publications Retired and Reaffirmed
Pediatrics 117: 1846-1847.[Full Text]
This article has been cited by other articles:
![]() |
Committee on Environmental Health and Committee on Chemical-Biological Terrorism and Its Impact on Children Pediatrics, September 1, 2006; 118(3): 1267 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Di Pentima, S. C. Eppes, and J. D. Klein Pediatricians Knowledge, Views, and Perspectives on Smallpox and Smallpox Vaccine Clinical Pediatrics, March 1, 2006; 45(2): 165 - 172. [Abstract] [PDF] |
||||
![]() |
D. Markenson, S. Reynolds, and Committee on Pediatric Emergency Medicine and Task The Pediatrician and Disaster Preparedness Pediatrics, February 1, 2006; 117(2): e340 - e362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Smallpox (Variola) Red Book, January 1, 2006; 2006(1): 591 - 595. [Full Text] |
||||
![]() |
R. B Quigley Uncertain Benefit: The Public Policy of Approving Smallpox Vaccine Research Am J Public Health, June 1, 2004; 94(6): 943 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Levine, R. Faden, C. Grady, D. Hammerschmidt, L. Eckenwiler, J. Sugarman, and on behalf of the Consortium to Examine Clinical Re "Special Scrutiny": A Targeted Form of Research Protocol Review Ann Intern Med, February 3, 2004; 140(3): 220 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Abramson, J. A. McMillan, and R. S. Baltimore The US Smallpox Vaccination Plan Pediatrics, June 1, 2003; 111(6): 1431 - 1432. [Full Text] [PDF] |
||||
![]() |
Smallpox (Variola) Red Book, January 1, 2003; 2003(1): 554 - 558. [Full Text] |
||||









